CO-FOUNDER

Dr. Li is an experienced radiochemist with research focusing on applying organic chemistry tools in radiolabeling and molecular imaging. Molecular imaging is a fast-growing research area involving the development and evaluation of novel tools, reagents, and methods to image specific molecular pathways in vivo; particularly those that are key targets in disease processes. Within this area of research, Positron emission tomography (PET) has emerged as one of the most powerful clinical imaging techniques, because it can provide critical in vivo information on the distribution of radiolabeled biomolecules for non-invasive diagnosis. Dr. Li’s research has been focused on the development and validation of novel radiolabeling methods and multimodality molecular imaging probes for visualization and quantification of various molecular targets related to neuro, cardiac, diabetes, and cancer research. Radiochemistry has been and continues to be, the central focus of his research. In particular, Dr. Li has been collaborating with Dr. Nicewicz to establish various photoredox based radiolabeling methods, which are powerful tools for PET probe construction.

CO-FOUNDER

Dr. Nicewicz is an expert in new organic reaction development, device fabrication, photochemistry and catalysis. He started the photoredox catalysis research area in the laboratory of Prof. David MacMillan while a postdoctoral researcher in Princeton in 2008. Since then, Dr. Nicewicz and his laboratory have explored the use of small molecule organic photoredox catalysts for use in novel organic transformations. Since 2015, Dr. Nicewicz has collaborated with Dr. Li in developing new radiolabeling reactions of small organic molecules for applications to Positron Emission Tomography (PET) imaging.